Industry Backs GDUFA II Proposals, Advancing Reauthorization of Fee Program

Drug Industry Daily
A A
Industry groups have backed the FDA’s commitment goals for GDUFA II, bringing the user fee program closer to reauthorization after Friday’s public meeting.

To View This Article:

Login

Subscribe To Drug Industry Daily